Microsurgery

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.

Retrieved on:

Monday, April 8, 2024

The FDA authorization makes the Symani Surgical System the only commercially available platform in the U.S. for reconstructive microsurgery.

Key Points:

The FDA authorization makes the Symani Surgical System the only commercially available platform in the U.S. for reconstructive microsurgery.
“With the authorization from the FDA, our technology will expand its reach to pioneering hospitals in the U.S.
The Symani Surgical System provides advanced solutions for a range of open surgeries, including post-mastectomy breast cancer reconstruction, extremity reconstruction using free tissue transfer, and lymphatic system repair.
MMI plans to immediately launch the technology in the U.S.
To learn more about MMI and the Symani Surgical System, visit MMI’s website here: https://mmimicro.com .

Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO

Retrieved on:

Thursday, March 28, 2024

McKinsey & Company, Growth, Mechanical engineering, Alcon, Cornell University, Sale, Medical device, Doctor of Philosophy, Bachelor, Truevision, Intuitive Surgical, Microsurgery, Health, Medtech, Management

This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.

Key Points:

This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.
Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
In his new role as CEO of Beyeonics Vision, Dr. Tripathi will lead the company's strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.
Yoram Shmuely, chairman of the Beyeonics Vision board, commented on the appointment, stating, "We believe Mr. Tripathi's leadership will continue to drive innovation and push forward Beyeonics Vision into the market.

MMI Raises $110 Million in Series C Financing

Retrieved on:

Wednesday, February 21, 2024

Technology, Surgery, Medical Devices, Health Technology, Biotechnology, Other Health, Health, Robotics, General Health, Hospital, Quality of life, Growth, Surgeon, Microsurgery, Patient, Trauma, Investment, Pharmaceutical industry

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing.

Key Points:

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing.
Investments will also accelerate advanced technology capabilities and enable MMI to scale its operational capabilities globally.
MMI and its existing investors, all of whom contributed to the Series C financing, see considerable opportunity for rapid growth.
To learn more about MMI and the Symani Surgical System, visit MMI’s website here: https://mmimicro.com .

NYC Plastic and Reconstructive Surgeon Dr. Casian Monaco Receives the 2024 Top Patient Rated Doctor Award from Find Local Doctors

Retrieved on:

Monday, March 4, 2024

Multimedia, Individual, Rhinoplasty, Breast, NYU, Society, Plastic, Doctor, Microsurgery, Patient, Elective surgery, UCLA, Nose, Face, Dentistry

NEW YORK, March 4, 2024 /PRNewswire-PRWeb/ -- Dr. Casian Monaco's state-of-the-art NYC practice stands as a hallmark of excellence in the field of plastic surgery, offering a full menu of services for the face, breast and body. Find Local Doctors has recognized him as a 2024 Top Patient Rated New York Doctor due to his large volume of five-star reviews from patients across multiple online sources. Find Local Doctors is an online directory that connects patients with highly skilled medical professionals in their area. Specializing in both aesthetic and reconstructive plastic surgery, Dr. Monaco's expertise covers a wide spectrum of procedures. His artistic vision is particularly evident in facial rejuvenation, rhinoplasty, breast augmentation and body contouring. Each procedure is tailored to reflect the individuality of the patient, ensuring outcomes that are not just beautiful but also harmoniously aligned with the person's unique physical characteristics and personal desires. At the core of Dr. Monaco's practice is a philosophy deeply rooted in patient satisfaction and well-being, believing in building a relationship with each patient based on trust, understanding and transparency.

Key Points:

Dr. Monaco is a board-certified plastic surgeon in New York City specializing in procedures of the face, nose, breast and body.
Find Local Doctors has recognized him as a 2024 Top Patient Rated New York Doctor due to his large volume of five-star reviews from patients across multiple online sources.
Find Local Doctors is an online directory that connects patients with highly skilled medical professionals in their area.
Specializing in both aesthetic and reconstructive plastic surgery, Dr. Monaco's expertise covers a wide spectrum of procedures.

Astra Plastic Surgery welcomes Dr. Pallavi Kumbla

Retrieved on:

Friday, February 16, 2024

Physician, Astra, Hand, Trauma, Science, Surgeon, Malignancy, Microsurgery, Patient, Dentistry

ATLANTA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and reconstructive surgery practice, is welcoming Dr. Pallavi Kumbla to its staff of seasoned physicians and surgeons at its Alpharetta and Cumming locations.

Key Points:

ATLANTA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and reconstructive surgery practice, is welcoming Dr. Pallavi Kumbla to its staff of seasoned physicians and surgeons at its Alpharetta and Cumming locations.
Dr. Kumbla trained alongside several prominent plastic and reconstructive surgeons performing complex craniofacial, hand, microsurgery, and aesthetic surgery, learning the comprehensive spectrum of plastic and reconstructive surgery.
“Our mission at Astra Plastic Surgery is to provide excellent care and a commitment to advancing the art and science of plastic and reconstructive surgery,” says Dr. Christopher Killingsworth, founder and managing partner of Astra Plastic Surgery.
Astra Plastic Surgery was established in 2012, recognizing the need for both cosmetic and reconstructive surgery in the North Atlanta area.

Signati™ Medical, Inc. Announces Board Member Dr. Jones Joins Urology Austin

Retrieved on:

Monday, February 12, 2024

Erectile dysfunction, Infertility, Leroy Jones, Male, Urinary incontinence, Urology, Premature ejaculation, Microsurgery, Medicine, MD

Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin.

Key Points:

Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin.
Dr. Jones has been on the leading edge of men’s sexual health and prosthetic surgery for decades.
As an industry leader in prosthetic surgery, Dr. Jones has performed more than 3,500 penile implants and artificial urinary sphincter procedures.
He specializes in erectile dysfunction, erectile growth enhancement, Peyronies Disease, low testosterone, premature ejaculation, urinary incontinence, and male infertility — vasectomies, reversals, and microsurgery.

EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24

Retrieved on:

Friday, February 9, 2024

Tax, SBU, Growth, Microsurgery, Pressure

Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%).

Key Points:

Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%).
Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG commented on the Q1 results: “We have made a solid start to the new fiscal year.
The strategic business unit Microsurgery achieved revenue growth of +10.6% (adjusted for currency effects: +13.7%) to €123.9m (prior year: €112.0m).
The APAC [2] region recorded a slight decline in revenue of -0.9% (adjusted for currency effects: +0.4%), to €206.4m (prior fiscal year: €208.2m).

SightMD Pennsylvania Welcomes David L. Silverman, MD to its Expert Team

Retrieved on:

Monday, February 5, 2024

HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.

Key Points:

SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
David L. Silverman, MD has been practicing comprehensive ophthalmology for nearly 30 years.
He is board certified by the American Board of Ophthalmology and is an active fellow of the American Academy of Ophthalmology.

MMI and ab medica Partner to Expand Access to Symani® Surgical System

Retrieved on:

Thursday, January 11, 2024

A distributor of pioneering robotic technologies for 40 years, ab medica will enhance MMI’s visibility across Italy and expand provider and patient access to microsurgical robotic technology.

Key Points:

A distributor of pioneering robotic technologies for 40 years, ab medica will enhance MMI’s visibility across Italy and expand provider and patient access to microsurgical robotic technology.
“ab medica has been on the leading edge of surgical robotics technology since the earliest days of the technology, and they are a highly trusted resource for innovators and healthcare providers,” said Nicola Matz, VP, EMEA Sales of MMI.
For healthcare providers already working with ab medica, this will create a seamless connection to the Symani Surgical System and help to meet the growing demand for these procedures.”
The Symani Surgical System is a first-of-its-kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery.
“We are deeply committed to advancing innovative technology in the operating room and are pleased to add the Symani Surgical System to our partnerships,” said Filippo Pacinotti, Business Director at ab medica.

EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent

Retrieved on:

Saturday, December 30, 2023

Tax, Marketing, Research, Microsurgery, SBU, Consumer, Annual, Growth, Investment, EUR, Supervisory board, Pharmaceutical industry

Carl Zeiss Meditec generated revenue of €2,089m in fiscal year 2022/23 (prior year: €1,903m), corresponding to growth of +9.8% (adjusted for currency effects: +10.1%).

Key Points:

Carl Zeiss Meditec generated revenue of €2,089m in fiscal year 2022/23 (prior year: €1,903m), corresponding to growth of +9.8% (adjusted for currency effects: +10.1%).
Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG: “We were able to further expand our market shares in both strategic business units despite an increasingly weakening economy.
Revenue in the strategic business unit (SBU) Ophthalmology increased by +7.3% in fiscal year 2022/23 (adjusted for currency effects: +7.6%), to €1,576m (prior year: €1,469m).
Good progress in equipment deliveries during the course of the fiscal year was a major contributor to revenue growth.